PROTEIN STRUCTURE, COAGULATION, FIBRINOLYSIS, INHIBITORS

Information

  • Research Project
  • 3335151
  • ApplicationId
    3335151
  • Core Project Number
    R01HL016238
  • Full Project Number
    5R01HL016238-12
  • Serial Number
    16238
  • FOA Number
  • Sub Project Id
  • Project Start Date
    12/1/1976 - 48 years ago
  • Project End Date
    3/31/1986 - 38 years ago
  • Program Officer Name
  • Budget Start Date
    4/1/1985 - 39 years ago
  • Budget End Date
    3/31/1986 - 38 years ago
  • Fiscal Year
    1985
  • Support Year
    12
  • Suffix
  • Award Notice Date
    -
Organizations

PROTEIN STRUCTURE, COAGULATION, FIBRINOLYSIS, INHIBITORS

In the first three-year period we completed the primary structure determination of prothrombin (including thrombin), identifying all the vitamin K-dependent modifications. During the second three-year period we determined the primary structures of plasminogen and antithrombin-III; and obtained crystals of the vitamin K-dependent domain from prothrombin which binds Ca++ and phospholipids and of a lysine-binding domain from plasminogen. During the third three-year period we have determine 98% of the primary structure of alpha2-macroglobulin and discovered a thiol ester at its protease-binding site. We have also clarified other aspects of the mechanism by which it inhibits proteinases such as those involved in coagulation and fibrinolysis. Over 55% of the primary structure of fibronectin has been determined, including the domain that binds fibrin and bacterial cells; that which contains the interchain disulfide bridges and is partly phosphorylated; and parts of those which bind gelatin and heparin. Our work on fibronectin has revealed three different sets of multiple internal homologies in this structure until now. In the present project it is proposed to finish the structure work on alpha2-macroglobulin, determine the complete primary structures of fibronectin, protein Z (one of the "new" vitamin K-dependent plasma proteins) and of C1-inactivator (an inhibitor both of complement component C1, and of plasma kallikrein in the early phase of coagulation); to continue work towards solving the tertiary structure of the crystalline prothrombin domain. Knowledge of these protein structures is directly or indirectly important for understanding molecular mechanisms related to thrombosis, fibrinolysis, opsonization, phagocytosis, aspects of malignant transformation, and survival after extensive trauma.

IC Name
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE
  • Activity
    R01
  • Administering IC
    HL
  • Application Type
    5
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    839
  • Ed Inst. Type
  • Funding ICs
  • Funding Mechanism
  • Study Section
    HEM
  • Study Section Name
    Hematology Subcommittee 2
  • Organization Name
    AARHUS UNIVERSITY HOSPITAL
  • Organization Department
  • Organization DUNS
  • Organization City
    AARHUS
  • Organization State
  • Organization Country
    DENMARK
  • Organization Zip Code
    8000
  • Organization District
    DENMARK